REVISTA DE PEDIATRÍA

CONCLUSIONES

Nuestro grupo de investigadores concluye que el grupo etáreo mas afectado en nuestro medio por el SGB son los menores a 18 años, en especial durante los primeros 8 años de vida. Las enfermedades mas relacionada a esta patología son las infecciones respiratorias altas y la diarrea, en especial la relacionada con el Campilovacter Jejuni; además se postula que el estudio del LCR y la VCN son de importancia como factor pronóstico en el curso de esta patología.

 

AGRADECIMIENTOS

Doctores: Armando Morales Ruiz, especialista en Bioestadística y profesor titular V de la Universidad de Cartagena y el Doctor Mariano Espinosa Cano, Magister en Bioepidemiología y profesor Instructor de la Universidad de Cartagena, Y los auxiliares de Estadística Omayda Bolívar Zuñiga y Reynaldo Cabrera Acendra.

BIBLIOGRAFIA

 

  1. Landry O. Note sur la pralysie ascendante aigue. Gazette hebdomadaire 1859; 6: 472-4.
  2. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction celluaire: Remarques sur les caracteres clinques et graphiques des reflexes tendineux. Bulletins et memories de la societe medicale des hospitaux de París, Masson et Cie 1916; 40: 1462-70.
  3. Guillain G, Barré JA. Travaux neurologiques de guerre. París, Masson et Cie, 1920.
  4. Haymarker W, Kernohan JW. The Landry-Guillain-Barré syndrome: A clinicopathologic report of fify fatal cases and a critique of the literarute. Medicine 1949; 28: 59-141.
  5. Waksman BH, Adams RD. Allergic neuritis: An experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjurants. J Exp Med 1955; 102: 213-35.
  6. Fisher CM. An unusual variant of facute idiophatic polyneuritis (syndrome of opthalmoplegia, ataxia and areflexia) N Engl J Med 1956; 255: 57-65.
  7. Oster L, Didell AD. The Guillain-Barré syndrome: The need for exact diagnostic criteria. N Engl J Med 1960; 262: 964-9.
  8. Melnick SC. Thirty-eight cases of the Guillain-Barré syndrome: an imunological study. Brit Med J 1963; 1: 368-73.
  9. Armason BGW. Inflamatory polyradiculoneuropathies. In: Dyck PJ, Thomas PK, Lambert EH. (eds.): Peripheral Neuropahy, Philadelphia,W.B. Saunders 1975, 2: 1110-48.
  10. Asbury AK. Diagnostic considerations in Guillain Barré syndrome. Ann Neurol 1981; 9(Suppl): 1-5.
  11. Eberle E, Brink S, Azen S, et al. Early predictors of incomplete recovery in children with Guillain-Barré polyneuritis. J Pediatr 1975; 86: 356-9.
  12. Gunderman JR. Guillain-Barré syndrome: occurrence following combined mumpus-rubella vaccine. Am J Dis Child 1973; 125: 834-5.
  13. Latovitzki N, Suciu-Foca N, Penn AS, et al. HLA typing and Guillain-Barré syndrome. Neurology 1979; 29: 743-5.
  14. Sheremata W, Colby S, Lusky G, et al. Cellular hypersensitization to peripheral nervous antingens in the Guillain-Barré syndorme. Neurology 1975; 25: 833-9.
  15. Beghi E, Kurland LT, Mulder DW, et al. Guillain-Barré syndrome: Clinicoepidemiiologic features and effect of influenza vaccine. Arch. Neurol. 1985; 42: 1053-7.
  16. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: A serological study. BMJ 1984; 288: 1867-70.
  17. Vrisendorp FJ, Mishu B, Blaser M, et al. Serum antibodies to GM1, pripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: Correlation and prognosis. Ann Neurol 1993, 34: 130-5.
  18. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disordes. Ann Neurol 1993; 34: 136-44.
  19. Rees Hj, Hughes RAC. Campylobacter jejuni anf Guillain-Barré syndrome. Ann Neurol 1994; 35: 248.
  20. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern Chia: Relationship to Campylober jejuni infection and antilgycolipid antibodies, Brain 1995; 118: 597-605.
  21. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neurophathy: A frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333-42.
  22. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996; 39: 17-28.
  23. Oomes PG, Jacobs BC, Hazenberg MPh, et al. AntiGM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: Evidence of molecular mimicry. Ann Neurol 1995; 38: 170-5.
  24. IIIa I, Ortiz N, Gallard E, et al. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 1995; 38: 218-24.
  25. Yuki N, Taki T, Takahasi M, et al. Penner´s serotype 4 of Campylobacter jejuni has a lopopolysaccharide that beras a GM1 ganglioside epitope as well as one that bears a D}-gd1a epitope. Infect Immun 1994; 62: 2101-3.
  26. Yiki N, Yamada M, Sato, S, et al. Association of IgG anti-Gd1 a antibody with severe Guillain-Barré syndrome. Muscle Nerve 1993; 16: 642-7.
  27. Yuk N, Yoshino H, Sato S, et al. Acute axonal polyneuropathy associated with anti-Gmantibodies following Campylober jejeuni enteritis. Neurology 1990; 40: 1900-2.
  28. Willison HJ, Veitc J. Immunoglobulin subclass distribution and binding characteristics of anti-GQqb antibodies in Miller Fisher syndrome. J Neurochem 1994, 50: 159-65.
  29. Willison HJ, Veitch J, Patterson G, et al. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neusurg Psychiatry 1993, 56: 204-6.
  30. Yuki N, Sato S, Tsuki S, et al. Frequent presence of anti-Gq1b antiblody in Fisher´s Syndrome. Neurology. Neurology 1993; 43: 414-7.
  31. Cole GF, Mathew DJ. Prognosis in Severe Guillain Barré Syndrome. Arc dis Child 1987; 62: 288-91.
  32. Evans CE. Polineuropathy in childhood. Pediactrics 1979, 64: 96-105.
  33. López f, López JH, Holguin J, et al. An outbreak of acute polyradiculloneoropathy in Colombia in 1968. Am J Epidemiol 1973; 98: 226-30.
  34. Sliman NA. Outbreak of Guillain-Barré associated with pollution, Br Med J 1978; 1: 751-2.
  35. Sconberger LB, Hurwitz ES, et al. Guillain-Barré syndrome: its epidemiology and associations with influenza vaccination. Ann Neurol 1981; 9(suppl.):31-8.
  36. Ordoñez N, Palacios E, Potes J. Síndrome de Guillain-Barré (polirradiculoneuritis). Monografía y revisión de 139 casos. Universitas Médica 1971,13: 15-48.
  37. Maestre OE, et al. Estudio epodemilógico de 340 casos del síndrome de Guillan Barré en el Hospital Universitario del Valle, cali, de 1957 a 1975. Acta Med Valle 1977;8: 109-14.
  38. Palacios E. Síndrome de Guillan Barré: Estudio clínico de 339 pacientes. Acta Med col 1982;7: 69-89.
  39. Correa P, García C, et al. Polineuropatías epidémicas agudas. Antioquia Med 1969; 19:337-40.
  40. Koobatian TJ, Birkhead GS, Schramm MM, et al. The use of hospital discharge data for public health surveillance of Guillain Barré syndrome. Ann Neurol 1992;30:618-21.
  41. Dov S, Feldman S, alter M. Epidemiology of Guillain Barré Syndrome. Neurol 1978;28:686-90.
  42. Soffer D, Feldman S, Alter M. Epidemiology of Guillain Barré Synfrome. Neurology 1978;28:686-90.
  43. Kennedy RH, Danielson MA, Mulder DW, Kurland LT. Guillain-Barré Syndrome: a 42 year epidemiological and clinical sstudy. Mayo Clin Proc 1978;53:93-9.
  44. Pascuzzi RM, Fleck JD. Acute peipheral neuropathy in adultos. Guillain-Barré Syndrome and related disorders. Neurologic clinics 1997;15:529-47.
  45. Lange DJ, Latov N, Trojaborg W. Acquired neuropathies. Rowland: Merritt´s Textobook of Neurology, 9th ed. Cpyright Williams & Wilkins 1995:650-76.
  46. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-6.
  47. Nance Pw, Kirby Rl. Rehabilitation of an adult with disabilities due to congenital sensory neuropathy. Arch Phys Med Rehabil 1985,66:123-8.
  48. Espinosa E, Hernández E, Medina C. Polirradiculoneuropatía tipo Guillain-Barré: Estudio neuroepidemiológico. Acta Neurol col 1998,4:7-14.
  49. Fernández W. El síndrome de Guillain-Barré en adultos. Estudio hospitalario y seguimiento extrahospitalario de 38 pacientes. Acta Neurol col 1988; 4: 145-9.
  50. Abwmar W, Lorenzana P. síndrome de Guillain-Barré recurrente. Acta Neurol Col 1995; 11: 31-6.
  51. Haymaker W, Kernohan JW. Landry-Guillain-Barré syndrome: Clinicopathologic report of 50 fatal cases and a critique of the literature. Medicina (Baltimore) 1949; 28: 59-141.
  52. Mcfarland HR, Heller GL. Guillain-Barré disease complex. Arch Neúrol 1966; 14: 196.
  53. Kraft GH, Ean. A model ol idiopathic polyneuritis. Arch Phys Med 1968;49: 490.
  54. Giraldo H, Piñeros J. Síndrome de Guillain-Barré. Análisis de 7 casos con severo compromiso respiratorio. Presentado en el IV Congreso Colombiano de Medicina Interna. Cali 1978.
  55. Pleasure DE, Lovelace RE, Fuvoisin RC. The prognosis of acutrre polyradiculoneuritis. Neurol 1968; 18: 1143-8 .
  56. Rudnicki s, Vriesendorp F, Koski CL, et al. Electrophusiologic studies in the Guillain-Barré syndrome: effects of plasma exchangue and antibody rebound. Muscle Nerve 1992; 15:57-60.
  57. McLeod JG: Electrophysiological studies in the Guillain-Barré syndrome. Ann Neurol 1981; 9(suppl): 20-277.
  58. Miller RG, Peterson GW, Daube JR, et al: Prognoctic value of electrodiagnosis in Guillain-Barré syndrome. Muscle Nerve 1988; 2 769-74.
  59. Ayala M, Toro J, Bernal P. Síndrome de Guillain-Barré. Experiencia en la fundación Santa Fe de Bogotá. Acta Med col 1993; 18: 237-43.

 

 

 

 Haga su consulta por tema

Búsqueda personalizada